Brian DiDonato
Director of Finance/CFO at IMMUNOCORE HOLDINGS PLC
Net worth: 1 M $ as of 2024-03-30
Profile
Brian R.
DiDonato is currently the Director at iECURE, Inc., EVP-Investments & Funds Management at Mortgage Investments LLC, and Chief Financial Officer & Head-Strategy at Immunocore Holdings Plc.
He previously worked as an Executive Director at Morgan Stanley Investment Management, Inc., Vice President at UBS Securities LLC, Managing Director at Sorin Capital Management LLC, EVP-Investments & Funds Management at Bluestem Group, Inc., and Chief Financial Officer & Senior Vice President at Achillion Pharmaceuticals, Inc. He also held positions as President at Capmark Investments LP and Engineering Officer at the US Department of Defense.
Mr. DiDonato received his undergraduate degree from Villanova University in 1988, his MBA from The Leonard N Stern School of Business in 1995, and another undergraduate degree from The Pennsylvania State University in 2018.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
0.05% | 2024-02-15 | 19,230 ( 0.05% ) | 1 M $ | 2024-03-30 |
Brian DiDonato active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Director of Finance/CFO | 2020-03-31 |
Mortgage Investments LLC
 Mortgage Investments LLC Financial ConglomeratesFinance Mortgage Investments LLC provides commercial real estate financing services. It provides permanent, construction, mezzanine, interim, and bridge loans. The company offers real estate lending, mortgage banking, servicing, investments, and funds management services. The company is headquartered in Horsham, PA. | Corporate Officer/Principal | 2005-10-31 |
IEcure, Inc.
 IEcure, Inc. BiotechnologyHealth Technology iECURE, Inc. is a gene editing company that focuses on developing therapies for liver disorders with significant unmet need. The company is based in Plymouth Meeting, PA, and the CEO of the company is Joseph Truitt. The company's approach involves mutation-agnostic in vivo gene insertion or knock-in editing, which has the potential to replace and restore the function of a dysfunctional gene, regardless of mutation. iECURE collaborates with the University of Pennsylvania's Gene Therapy Program to utilize their translational expertise and infrastructure. The company's management team has extensive experience in executing orphan drug and gene therapy clinical trials and successfully commercializing multiple products. iECURE's programs are currently focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases. | Director/Board Member | 2021-08-31 |
Former positions of Brian DiDonato
| Companies | Position | End |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Director of Finance/CFO | 2020-04-30 |
Sorin Capital Management LLC
 Sorin Capital Management LLC Investment ManagersFinance Founded by James Higgins in 2004, Sorin Capital Management LLC is registered investment and hedge fund manager headquartered in Stamford, Connecticut. The firm is wholly-owned by Sorin Investment Group LP, a Delaware limited partnership, which is owned by the firm’s CEO, James J. Higgins, and a related Higgins family trust, their Senior Portfolio Manager and Head Trader, Thomas Digan, and the firm’s CFO, Thomas Tam. Sorin Capital Management's clients consist of private funds, managed accounts and investment companies. | Portfolio Manager-Fixed Income | 2014-11-30 |
Capmark Investments LP
 Capmark Investments LP Investment ManagersFinance Founded in 2000, Capmark Investments, formerly GMAC Institutional Advisors LLC, is a registered investment advisory firm headquartered in Horsham, Pennsylvania. They are a subsidiary of TRECAP Partners LLC | President | 2008-03-30 |
| BLUM GROU | Corporate Officer/Principal | 2008-03-30 |
Morgan Stanley Investment Management, Inc.
 Morgan Stanley Investment Management, Inc. Investment ManagersFinance Morgan Stanley Investment Management, Inc. (MSIM) is an investment management firm headquartered in New York City. The firm was founded in 1975 and is a subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately held by Morgan Stanley (NYSE: MS). MSIM provides discretionary and non-discretionary investment management services and products to institutional clients and individual investors. The firm also advises clients as to the appropriate allocation of assets among multiple separate accounts and/or investment companies or other pooled vehicles that the firm advises. | Corporate Officer/Principal | 2001-12-31 |
Training of Brian DiDonato
| The Pennsylvania State University | Undergraduate Degree |
| Villanova University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BLUM GROU | Retail Trade |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private companies | 8 |
|---|---|
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Morgan Stanley Investment Management, Inc.
Morgan Stanley Investment Management, Inc. Investment ManagersFinance Morgan Stanley Investment Management, Inc. (MSIM) is an investment management firm headquartered in New York City. The firm was founded in 1975 and is a subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately held by Morgan Stanley (NYSE: MS). MSIM provides discretionary and non-discretionary investment management services and products to institutional clients and individual investors. The firm also advises clients as to the appropriate allocation of assets among multiple separate accounts and/or investment companies or other pooled vehicles that the firm advises. | Finance |
Capmark Investments LP
Capmark Investments LP Investment ManagersFinance Founded in 2000, Capmark Investments, formerly GMAC Institutional Advisors LLC, is a registered investment advisory firm headquartered in Horsham, Pennsylvania. They are a subsidiary of TRECAP Partners LLC | Finance |
| US Department of Defense (District of Columbia) | Government |
Sorin Capital Management LLC
Sorin Capital Management LLC Investment ManagersFinance Founded by James Higgins in 2004, Sorin Capital Management LLC is registered investment and hedge fund manager headquartered in Stamford, Connecticut. The firm is wholly-owned by Sorin Investment Group LP, a Delaware limited partnership, which is owned by the firm’s CEO, James J. Higgins, and a related Higgins family trust, their Senior Portfolio Manager and Head Trader, Thomas Digan, and the firm’s CFO, Thomas Tam. Sorin Capital Management's clients consist of private funds, managed accounts and investment companies. | Finance |
Mortgage Investments LLC
Mortgage Investments LLC Financial ConglomeratesFinance Mortgage Investments LLC provides commercial real estate financing services. It provides permanent, construction, mezzanine, interim, and bridge loans. The company offers real estate lending, mortgage banking, servicing, investments, and funds management services. The company is headquartered in Horsham, PA. | Finance |
IEcure, Inc.
IEcure, Inc. BiotechnologyHealth Technology iECURE, Inc. is a gene editing company that focuses on developing therapies for liver disorders with significant unmet need. The company is based in Plymouth Meeting, PA, and the CEO of the company is Joseph Truitt. The company's approach involves mutation-agnostic in vivo gene insertion or knock-in editing, which has the potential to replace and restore the function of a dysfunctional gene, regardless of mutation. iECURE collaborates with the University of Pennsylvania's Gene Therapy Program to utilize their translational expertise and infrastructure. The company's management team has extensive experience in executing orphan drug and gene therapy clinical trials and successfully commercializing multiple products. iECURE's programs are currently focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases. | Health Technology |
- Stock Market
- Insiders
- Brian DiDonato
